Patents by Inventor Jeff Ohmen

Jeff Ohmen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene and sequence variation associated with lipid disorder
    Publication number: 20030064372
    Abstract: The present invention relates to the discovery of gene and its sequence variation associated with lipid disorder and cancer. The present invention also relates to the study of metabolic pathways and cellular mechanisms to identify other genes, receptors, and relationships that contribute to lipid disorder and cancer. The present invention also relates to germline or somatic sequence variation and its use in the diagnosis and prognosis of predisposition to lipid disorder and cancer. The present invention also provides primers or probes specific for the detection and analysis of such sequence variation. The present invention also relates to methods to screen drugs for inhibition or restoration of gene function as an anti-lipid disorder or anti-cancer therapy. Finally, the present invention relates to other anti-lipid disorder or anti-cancer therapies, such as gene therapy, protein replacement therapy, etc.
    Type: Application
    Filed: September 7, 2001
    Publication date: April 3, 2003
    Inventors: Jackie S. Bodnar, Lawrence W. Castellani, Aurobindo Chatterjee, Pieter de Jong, Aldons JAKE Lusis, Jeff Ohmen, David Ross, Sherrie Tafuri, Chenyan Wu
  • Gene and sequence variation associated with cancer
    Publication number: 20030054418
    Abstract: The present invention relates to the discovery of gene and its sequence variation associated with lipid disorder and cancer. The present invention also relates to the study of metabolic pathways and cellular mechanisms to identify other genes, receptors, and relationships that contribute to lipid disorder and cancer. The present invention also relates to germline or somatic sequence variation and its use in the diagnosis and prognosis of predisposition to lipid disorder and cancer. The present invention also provides primers or probes specific for the detection and analysis of such sequence variation. The present invention also relates to methods to screen drugs for inhibition or restoration of gene function as an anti-lipid disorder or anti-cancer therapy. Finally, the present invention relates to other anti-lipid disorder or anti-cancer therapies, such as gene therapy, protein replacement therapy, etc.
    Type: Application
    Filed: September 7, 2001
    Publication date: March 20, 2003
    Inventors: Jackie S. Bodnar, Lawrence W. Castellani, Aurobindo Chatterjee, Pieter de Jong, Aldons Jake Lusis, Jeff Ohmen, David Ross, Sherrie Tafuri, Chenyan Wu